Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Praluent
Pharma
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
The FDA has approved Merck's cholesterol-lowering daily pill Lipfendra. The PCSK9 inhibitor has been cleared for adults with hypercholesterolemia.
Kevin Dunleavy
Jul 16, 2026 9:30am
Regeneron unveils latest drug pricing accord with White House
Apr 23, 2026 2:17pm
FDA endorses LIB's convenient cholesterol-lowering PCSK9 drug
Dec 15, 2025 11:33am
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Aug 8, 2025 9:32am
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
May 15, 2025 3:52pm
Sanofi, Regeneron clinch win in PCSK9 patent feud with Amgen
May 18, 2023 3:16pm
